# Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum

> **NCT00086931** · PHASE1,PHASE2 · COMPLETED · sponsor: **Roswell Park Cancer Institute** · enrollment: 37 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** capecitabine
- **DRUG:** oxaliplatin
- **PROCEDURE:** conventional surgery
- **PROCEDURE:** neoadjuvant therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00086931
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2007-05
- **Final completion:** 2010-05
- **Target enrollment:** 37 (ACTUAL)
- **Last updated:** 2013-03-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00086931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00086931, "Oxaliplatin, Capecitabine, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Rectum". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT00086931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*